Cost analysis of erythropoietin versus blood transfusions for cervical cancer patients receiving chemoradiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 51, Issue 2, 2001, Pages 435-441

  Kavanagh, Brian D ^a,c   Fischer IV, Bernard A ^a   Segreti, Eileen M ^b   Wheelock, John B ^b   Boardman, Cecilia ^b   Roseff, Susan D ^b   Cardinale, Robert M ^a   Benedict, Stanley H ^a   Goram, Adrian L ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Cervical cancer; Cost; Erythropoietin; Radiotherapy; Transfusion

Indexed keywords

RED BLOOD CELLS (RBC);

BLOOD; CHEMOTHERAPY; HEMOGLOBIN; PATIENT TREATMENT; TUMORS;

RADIOTHERAPY;

CISPLATIN; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; FEMALE; HUMAN; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CISPLATIN; COSTS AND COST ANALYSIS; ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIN; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; MIDDLE AGED; PROBABILITY; RADIATION-SENSITIZING AGENTS; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 0035479083     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01645-5     Document Type: Article

References (35)

1. The significance of anemia in clinical radiation therapy
2. Anemia, hypoxia and transfusion in patients with cervix cancer; A review
3. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
4. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
5. Interaction of platinum drugs with clinically relevant x-ray doses in mammalian cells; A comparison of cisplatin, carboplatin, iproplatin, and tetraplatin
6. Erythropoietin increases hemoglobin during radiation therapy for cervical cancer
7. Erythropoietin increases hemoglobin in cancer patients during radiation therapy
8. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy; Preliminary results of a randomized, open-labeled, phase II trial
9. Erythropoietin decreases transfusion requirements during radiochemotherapy
10. IgA anaphylactic transfusion reactions
11. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States
12. Costs of HIV medical care in the era of highly active antiretroviral therapy
13. Impact of protease inhibitors and other antiretroviral treatments on acquired immunodeficiency syndrome survival in San Francisco, California, 1987-1996
14. The risk of transfusion-transmitted viral infections
15. The economic burden of hepatitis B in Germany
16. Cost effectiveness of interferon alpha2b combined with ribavirin for the treatment of chronic hepatitis C
17. Outcomes analyses of the outpatient treatment of venous thromboembolic disease using the low-molecular-weight heparin enoxaparin in a managed care organization
18. Analysis of the cost effectiveness of concurrent cisplatin-based chemoradiation in cervical cancer; Implications from five randomized trials
19. A cost-effectiveness analysis of epoetin usage for patients with AIDS
20. Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life; A randomized, placebo-controlled trial
21. A cost analysis comparing erythropoietin and red cell transfusions in the treatment of anemia of prematurity
22. Cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia
23. Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia
24. What are cancer patients willing to pay for prophylactic epoetin alfa? A cost-benefit analysis
25. Cost of managing anemia with and without prophylactic epoetin alfa therapy in breast cancer patients receiving combination chemotherapy
26. The effect of flunarizine on erythrocyte suspension viscosity under conditions of extreme hypoxia, low pH, and lactate treatment
27. Erythropoietin-induced rheological changes of rat erythrocytes
28. Changes of blood oxygen affinity in different CPD solutions during liquid storage
29. A phase I study of RSR13, a radiation-enhancing hemoglobin modifier; Tolerance of repeated intravenous doses and correlation of pharmacokinetics with pharmacodynamics
30. NAT of the United States and Canadian blood supply
31. Blood transfusion, first of two parts
32. Blood transfusion immunomodulation; The silent epidemic
33. Universal WBC leukoreduction
34. NAT and blood safety; What is the paradigm?